In the BioHarmony Drug Report Database

"Preview" Icon

Tamoxifen

Nolvadex, Soltamox (tamoxifen) is a small molecule pharmaceutical. Tamoxifen was first approved as Nolvadex on 1982-01-01. It is used to treat breast neoplasms, gynecomastia, pancreatic neoplasms, and precocious puberty in the USA. The pharmaceutical is active against estrogen receptor. In addition, it is known to target estrogen receptor beta, G-protein coupled estrogen receptor 1, and 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase.

 

Trade Name

 

Nolvadex, Soltamox
 

Common Name

 

tamoxifen
 

ChEMBL ID

 

CHEMBL83
 

Indication

 

breast neoplasms, gynecomastia, pancreatic neoplasms, precocious puberty
 

Drug Class

 

Selective estrogen receptor modulator

Image (chem structure or protein)

Tamoxifen structure rendering